Last $1.05 USD
Change Today +0.0702 / 7.16%
Volume 5.3M
LXRX On Other Exchanges
Symbol
Exchange
LXRX is not on other exchanges.
As of 8:10 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alan J. Main Ph.D.

Executive Vice President of Pharmaceutical Research, Lexicon Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

60$920,842
As of Fiscal Year 2013

Background*

Dr. Alan J. Main, Ph.D. has been an Executive Vice President of Pharmaceutical Research at Lexicon Pharmaceuticals Inc. since February 26, 2007. Dr. Main served as Senior Vice President of Lexicon Pharmaceuticals Inc. from July 2001 to February 26, 2007. He served as President, Chief Executive Officer and Director of Coelacanth Chemical Corporation from January 2000 until Lexicon Pharmaceuticals Inc.'s acquisition of Coelacanth in July 2001. Before joining Coelacanth, ...

Read Full Background

Corporate Headquarters*

8800 Technology Forest Place
The Woodlands, Texas 77381

United States

Phone: 281-863-3000
Fax: 281-863-8088

Board Members Memberships*

Board Member, President and Chief Executive Officer
Former Director

Education*

PhD
University of Liverpool
Post-Doctoral Training
Woodward Research Institute
BS
University Of Aberdeen

Other Affiliations*

Annual Compensation*

Salary$355,833
Total Annual Compensation$355,833

Stock Options*

Restricted Stock Awards$137,940
All Other Compensation$6,887
Exercisable Options1,414,088
Exercisable Options Value$113,750
Unexercisable Options504,912
Total Value of Options$113,750
Total Number of Options1,919,000

Total Compensation*

Total Annual Cash Compensation$362,720
Total Short Term Compensation$355,833
Other Long Term Compensation$144,827
Total Calculated Compensation$920,842
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LXRX:US $1.05 USD +0.0702

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
Timothy M. Ring Chairman, Chief Executive Officer and Chairman of Executive Committee
CR Bard Inc.
$1.1M
Michael F. Mahoney Chief Executive Officer, President and Director
Boston Scientific Corporation
$900.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEXICON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.